VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
LH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
LHLabcorp Holdings Inc.
$303.98$24.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLHBalance Sheet

Labcorp Holdings Inc. (LH) Balance Sheet

30Y historyFree accessUpdated daily

Debt-to-equity stands at 0.78 with total debt of $6.8B, while cash has thinned to $141.8M, indicating a reliance on operating cash flow and a need to monitor liquidity.

Income StatementBalance SheetCash FlowRatios

LH Balance Sheet

Annual statement

LH Balance Sheet

Labcorp Holdings Inc. (LH) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets3.81B4.02B4.81B3.77B4.63B5.33B5.13B2.98B2.84B2.68B2.48B2.66B1.69B1.19B1.19B859.1M1.14B935.6M1.03B937.5M887M702.3M740M657.9M596.7M624.5M511.7M499.5M519.1M527.6M721.5M
Cash & Short-Term Investments141.8M532.3M1.52B536.8M320.6M1.47B1.32B337.5M426.8M316.7M433.6M716.4M580M404M466.8M159.3M230.7M148.5M219.7M166.3M186.9M63.1M206.8M123M56.4M149.2M48.8M40.3M22.7M23.3M29.3M
Cash Only141.8M532.3M1.52B536.8M320.6M1.47B1.32B337.5M426.8M316.6M433.6M716.4M580M404M466.8M159.3M230.7M148.5M219.7M56.4M51.5M45.4M186.8M123M56.4M149.2M48.8M40.3M22.7M23.3M29.3M
Short-Term Investments0000000000000000000109.9M135.4M17.7M20M00000000
Accounts Receivable2.5B2.26B2.1B2.1B2B2.98B3.02B2.03B1.86B1.85B1.52B1.37B815.7M784.7M718.5M699.8M655.6M574.2M631.6M623.2M541.3M493.4M441.4M432.5M393M365.5M368M348M375.4M330.6M505.6M
Days Sales Outstanding60.359.1458.8462.9961.4582.7678.7763.9859.9864.5857.4957.849.5349.3146.2446.0947.8244.6451.1755.9155.0254.1252.2353.7157.260.6569.9874.7784.9779.44114.79
Inventory562.2M534.7M493.2M474.6M470.6M401.4M423.2M244.7M237.3M227.6M205.2M191M139.5M136.5M121M110.8M103.4M90M91M80.4M84.3M65.4M61.5M47M44.8M38.7M31.6M29.1M30.7M36M44.3M
Days Inventory Outstanding18.6519.119.1819.6921.0617.9917.1110.7610.6211.9111.5912.0713.3713.912.9112.3812.9912.0612.6212.3514.9312.3212.51011.3111.0910.5210.4511.2512.8314.32
Other Current Assets606.1M1697.6M655.3M1.84B000088.9M148.3M164.9M0106.9M85.5M114.9M58.4M42.8M6.7M021.3M43.2M1.1M19.1M57.1M54.4M63.3M82.1M90.3M137.7M142.3M
Total Non-Current Assets14.72B14.37B13.57B12.96B15.53B15.05B14.95B15.04B13.35B13.89B11.77B11.62B5.61B5.76B5.62B5.31B5.04B3.9B3.64B3.43B3.11B3.17B2.86B2.76B2.02B1.31B1.16B1.09B1.12B1.13B1.2B
Property, Plant & Equipment3.1B3.08B3.05B2.91B2.79B2.82B2.73B2.61B1.78B1.75B1.72B1.75B786.5M707.4M630.8M578.3M586.9M500.8M496.4M439.2M393.2M381.5M360M361.3M351.2M309.3M272.8M273.2M259.1M254.9M282.9M
Fixed Asset Turnover4.64x4.53x4.27x4.18x4.25x4.67x5.12x4.42x6.35x5.97x5.61x4.97x7.64x8.21x8.99x9.58x8.53x9.37x9.08x9.26x9.13x8.72x8.57x8.14x7.14x7.11x7.04x6.22x6.22x5.96x5.68x
Goodwill7.03B6.79B6.37B6.14B6.12B7.96B7.75B7.87B7.36B7.53B6.42B6.29B3.1B3.02B2.9B2.68B2.6B1.9B1.77B1.64B1.48B0000000000
Intangible Assets3.68B3.6B3.49B3.34B3.12B3.74B3.96B4.03B3.91B4.34B3.4B3.32B1.48B1.57B1.67B1.62B1.67B1.34B1.22B613.4M610.2M2.12B1.86B1.86B1.22B968.5M865.7M803.9M836.2M851.3M891.1M
Long-Term Investments608M153.9M16.3M26.9M65.7M60.9M73.5M84.9M60.5M58.4M57.6M58.2M92.6M88.5M78.1M76.8M78.5M71.4M72M000000000000
Other Non-Current Assets769.3M751.3M652.2M536.5M3.42B462.6M410M435.4M276M605.3M165.1M150M154.8M143.1M124.9M94.2M103.2M90.7M73.5M738.6M626.4M669.3M643.5M538.4M426.6M27.3M16.7M13.6M26.5M24.7M21.5M
Total Assets18.53B18.39B18.38B16.73B20.16B20.39B20.07B18.02B16.19B16.57B14.25B14.29B7.3B6.95B6.81B6.17B6.19B4.84B4.67B4.37B4B3.88B3.6B3.41B2.61B1.93B1.67B1.59B1.64B1.66B1.92B
Asset Turnover0.77x0.76x0.71x0.73x0.59x0.64x0.70x0.64x0.70x0.63x0.68x0.61x0.82x0.84x0.83x0.90x0.81x0.97x0.96x0.93x0.90x0.86x0.86x0.86x0.96x1.14x1.15x1.07x0.98x0.92x0.84x
Asset Growth %9.23%0.07%9.89%-17.02%-1.13%1.56%11.38%11.34%-2.31%16.29%-0.27%95.65%5.07%2.05%10.35%-0.27%27.91%3.6%6.9%9.18%3.23%7.63%5.45%30.75%35.35%15.76%4.82%-3.09%-1.06%-13.48%4.34%
Total Current Liabilities2.12B2.82B3.33B3.23B3.08B2.78B3.08B2.66B1.88B2.19B1.83B1.7B976.3M735.7M1.03B732.6M1.12B1.02B546.9M967.9M930.9M888.1M300.8M757.6M226.4M201.2M311.9M245.6M251.4M196.6M252.8M
Accounts Payable688.5M840.8M875.8M827.5M852.2M621.3M638.9M632.3M634.6M573.9M508.4M497.4M282.3M304.5M236.9M257.8M257.8M183.1M159.7M134.2M133.5M116.2M85.3M73M79.9M60.2M52.8M43.6M50.2M55.9M65.7M
Days Payables Outstanding25.5130.0334.0634.3438.1427.8525.8427.828.430.0228.7231.4327.063125.2728.832.3824.5422.1520.6123.6421.8917.3415.5420.1717.2417.5715.6618.419.9221.24
Short-Term Debt900K695.8M1B999.8M301.3M1.5M376.7M415.2M10M409.2M541.1M418.5M343.9M110.8M480M135.5M361.7M417.2M120.8M589.5M554.4M544.6M100K523.5M400K0132M95M72.5M018.7M
Deferred Revenue (Current)1.62B439.1M392.2M421.7M310.6M558.5M506.5M451M356.4M380.8M176M146.1M0000000000000000000
Other Current Liabilities0847.8M495.4M431.4M1.1B735.5M623.2M474.6M427.6M432.8M346.2M353.7M204.2M199.4M177.9M188.9M148.1M142.4M09.9M7.7M00000127.1M107M128.7M140.7M168.4M
Current Ratio1.80x1.42x1.44x1.17x1.50x1.92x1.66x1.12x1.51x1.23x1.36x1.57x1.73x1.62x1.15x1.17x1.02x0.92x1.89x0.97x0.95x0.79x2.46x0.87x2.64x3.10x1.64x2.03x2.06x2.68x2.85x
Quick Ratio1.53x1.23x1.30x1.02x1.35x1.77x1.53x1.03x1.38x1.12x1.24x1.45x1.59x1.43x1.03x1.02x0.93x0.83x1.72x0.89x0.86x0.72x2.26x0.81x2.44x2.91x1.54x1.92x1.94x2.50x2.68x
Cash Conversion Cycle53.4548.2143.9648.3444.3772.970.0546.9442.246.4740.3638.4435.8432.2133.8829.6728.4332.1741.6447.6546.3144.5547.3948.1748.3454.4962.9369.5777.8272.35107.87
Total Non-Current Liabilities7.78B6.93B6.98B5.61B6.96B7.31B7.54B7.8B7.32B7.66B6.9B7.44B3.49B3.72B3.03B2.86B2.58B1.71B2.31B1.68B1.09B1.1B1.33B761.4M742.3M643M477.6M610.4M708.3M831.9M1.41B
Long-Term Debt5.86B5.77B5.33B4.05B5.04B5.42B5.42B5.79B5.99B6.29B5.24B5.88B2.64B2.88B2.17B2.09B1.83B977.2M1.6B1.08B603M604.5M889.3M356.3M516M502.8M353.7M482.8M575.5M689.6M1.26B
Capital Lease Obligations2.94B745.6M750.6M727.5M736.5M727.1M762M687.7M51M57.8M56.2M55.5M39.2M14.1M0-5.9M0000002.9M4.4M5.5M6.1M00000
Deferred Tax Liabilities1.84B454.5M383.1M417.9M543.4M762.9M828.5M942.8M940M875.5M1.21B1.18B530.4M563.9M546M477.9M602.3M577.7M522.9M506.8M409.2M408.9M346.2M273.4M79.3M000000
Other Non-Current Liabilities717.6M-34.8M517.4M409.3M642.4M402M526.4M383.2M334M442.3M392M320.6M270.8M262.5M302M286.2M151.4M158.4M189.6M90.7M80.6M88.6M87.6M127.3M141.5M134.1M123.9M127.6M132.8M142.3M144.5M
Total Liabilities9.91B9.76B10.31B8.83B10.04B10.09B10.61B10.46B9.19B9.85B8.73B9.14B4.46B4.46B4.06B3.59B3.7B2.73B2.86B2.64B2.02B1.99B1.63B1.52B968.7M844.2M789.5M856M959.7M1.03B1.66B
Total Debt6.77B7.2B7.27B5.95B6.25B6.34B6.76B7.11B6.06B6.76B5.85B6.36B3.03B3B2.65B2.22B2.19B1.39B1.72B1.67B1.16B1.15B892.3M884.2M521.9M508.9M485.7M577.8M648M689.6M1.28B
Net Debt6.62B6.67B5.75B5.42B5.93B4.87B5.44B6.77B5.63B6.45B5.42B5.65B2.45B2.6B2.19B2.06B1.96B1.25B1.5B1.61B1.11B1.1B705.5M761.2M465.5M359.7M436.9M537.5M625.3M666.3M1.25B
Debt / Equity0.78x0.83x0.90x0.75x0.62x0.62x0.71x0.94x0.87x0.99x1.06x1.28x1.07x1.20x0.97x0.88x0.88x0.66x0.95x0.97x0.59x0.61x0.45x0.47x0.32x0.47x0.55x0.79x0.95x1.09x4.96x
Debt / EBITDA2.92x3.28x4.20x4.57x3.16x1.75x2.07x3.38x3.23x3.56x3.24x4.36x2.62x2.80x2.39x2.15x2.08x1.40x1.91x1.77x1.36x1.50x1.21x1.32x0.97x1.08x1.43x2.47x3.06x--
Net Debt / EBITDA2.86x3.04x3.33x4.16x3.00x1.34x1.66x3.22x3.00x3.40x3.00x3.87x2.12x2.42x1.97x1.99x1.86x1.25x1.67x1.71x1.30x1.44x0.96x1.14x0.87x0.76x1.29x2.30x2.95x--
Interest Coverage6.41x5.94x5.61x3.85x7.88x14.63x11.70x5.59x6.19x5.58x6.02x3.64x8.49x10.49x10.99x10.90x14.08x15.06x11.91x------------
Total Equity8.62B8.64B8.07B7.89B10.12B10.29B9.46B7.59B6.99B6.82B5.52B4.96B2.84B2.51B2.74B2.52B2.49B2.11B1.81B1.73B1.98B1.89B2B1.9B1.61B1.09B877.4M734.2M681.2M630M258.1M
Equity Growth %20.18%7.07%2.23%-22%-1.73%8.85%24.65%8.53%2.43%23.62%11.31%74.76%13.04%-8.3%8.5%1.48%18.08%16.38%4.89%-12.74%4.85%-5.68%5.45%17.63%48.49%23.71%19.5%7.78%8.13%144.09%-37.29%
Book Value per Share105.16103.0695.5790.07110.43105.5896.5076.9568.1365.6952.9349.3032.8527.3528.1124.7923.5919.3015.9914.2214.8413.2313.4912.4611.207.6815.6313.4813.5212.815.25
Total Shareholders' Equity8.61B8.62B8.05B7.88B10.1B10.27B9.44B7.57B6.97B6.8B5.51B4.95B2.82B2.49B2.72B2.5B2.47B2.11B1.69B1.73B1.98B1.89B2B1.9B1.61B1.09B877.4M734.2M681.2M630M258.1M
Common Stock7.3M7.5M7.6M7.7M8.1M8.5M9M9M11.7M12M12.1M12M10.4M10.5M11.3M11.7M12.2M12.5M12.8M13.2M14.4M14.8M15.1M14.9M14.8M7.1M3.5M1.3M000
Retained Earnings8.7B8.64B8.3B7.89B10.58B10.46B9.48B7.9B7.08B6.22B4.96B4.22B3.79B3.37B3.59B3.39B3.25B2.93B2.6B2.24B1.77B1.34B950.1M587.1M266.1M11.5M-168M-245.5M-260.5M-284.9M-154.1M
Treasury Stock00000000-1.11B-1.06B-1.01B-978.1M-965.5M-958.9M-951.8M-940.9M-934.9M-932.5M-929.8M-897.1M-891.6M-888.5M-544.2M-159.3M-4.4M000000
Accumulated OCI-101.9M-27.6M-261.6M-59.3M-493.2M-192M-161.9M-372.4M-463.1M-335.7M-581.1M-221.1M-10.5M66.2M69.4M45.5M88.5M61.5M-16.7M120M58.7M83.4M74.2M12.3M-71.3M-22M-9.8M-4.2M-174.7M-204.9M-174.7M
Minority Interest16.4M16.9M14.3M15.5M18.9M20.6M20.7M20.1M19.1M20.8M15.2M14.9M17.7M19.4M20.7M20.2M20.6M0121.3M000000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Regulatory LDT oversight

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Creeps Higher Amid Expansion

Total assets grew from $16.5B in 2024Q1 to $18.5B in 2026Q2, while debt-to-equity rose from 0.75 to 0.78, per recent SEC filings, indicating a balance sheet expanding with modest leverage.

The sequential increase in total assets, particularly in goodwill and PPE, suggests continued investment in acquisitions and infrastructure. However, the rise in D/E from 0.75 to 0.78 over the period, despite a slight dip in 2026Q1, implies that growth is partly debt-funded. This trend, coupled with the recent spin-off, may indicate a deliberate strategy to leverage the core diagnostics business, but investors should monitor whether this leverage remains within manageable bounds.

Debt Load Stabilizes After Spin-Off

Total debt hovered around $7.2B in 2025, then dipped to $6.8B in 2026Q2, with D/E at 0.78, as reported in financial statements, suggesting a deleveraging trend post-Fortrea spin-off.

The reduction in total debt from $7.3B in 2024Q4 to $6.8B in 2026Q2, alongside a stable equity base, indicates that management is prioritizing balance sheet strength. The D/E ratio of 0.78 remains below peer Quest's 0.95, suggesting a relatively conservative leverage profile. However, the absolute debt level of $6.8B still represents a significant fixed obligation, and with cash reserves of only $141.8M in 2026Q2, the company's liquidity buffer against debt servicing is thin, warranting close attention to cash flow generation.

Goodwill Dominates Asset Base

Goodwill rose from $6.2B in 2024Q1 to $7.0B in 2026Q2, now representing 38% of total assets, based on reported figures, highlighting the acquisitive nature of Labcorp's growth strategy.

The steady increase in goodwill, up $0.8B over the period, reflects a continued M&A-driven approach, consistent with management's historical 'bolt-on' strategy. While this has expanded the asset base, it also raises the risk of future impairment if acquired businesses underperform. In contrast, PPE has remained relatively flat at $3.1B, suggesting that organic capital expenditure is not keeping pace with acquisition-driven growth, which may indicate a reliance on acquisitions rather than internal investment for expansion.

Retained Earnings Steady, Buybacks Continue

Retained earnings grew from $8.1B in 2024Q1 to $8.7B in 2026Q2, while equity remained around $8.6B, as per recent financial statements, indicating a stable equity base despite ongoing share repurchases.

The modest increase in retained earnings, despite aggressive buybacks ($353.8M in 2026Q2 alone), suggests that net income is being partially offset by capital returns. The stability of total equity, hovering between $8.0B and $8.7B, implies that the company is effectively recycling earnings into buybacks and dividends rather than building a larger equity cushion. This approach may enhance shareholder returns but could also limit financial flexibility in a downturn.

Liquidity Cushion Thins to Multi-Year Low

Cash dropped from $1.5B in 2024Q4 to $141.8M in 2026Q2, while the current ratio improved to 1.80, according to recent SEC filings, suggesting a reliance on operating cash flow rather than cash reserves.

The dramatic decline in cash, from $1.5B to $141.8M, is striking, yet the current ratio has improved from 1.44 to 1.80, indicating that current assets are more than covering short-term liabilities. This paradox suggests that the company is deploying its cash into working capital and investments, possibly to fund growth. However, the thin cash position leaves little room for unexpected shocks, and the company may need to rely on credit lines or debt issuance if cash flow falters.

Deferred Revenue Signals Pipeline Strength

Deferred revenue remained stable around $390M over the past ten quarters, with 2026Q2 at $387.8M, as reported in financial statements, suggesting a consistent backlog of services yet to be recognized.

The stability of deferred revenue, despite the spin-off and revenue growth, implies that the company's contract-based revenue streams are not expanding significantly. This could indicate that the growth is driven more by transactional volume than by long-term contracts, which may be less predictable. Investors should monitor whether deferred revenue grows in line with revenue, as a divergence could signal changes in the business mix or contract terms.

LH — Frequently Asked Questions

Quick answers to the most common questions about buying LH stock.

What are the total assets of Labcorp Holdings Inc. (LH)?

As of 2025, Labcorp Holdings Inc. (LH) had total assets of $18.39B including $4.02B in current assets.

How much debt does Labcorp Holdings Inc. (LH) have?

Labcorp Holdings Inc. (LH) carries total debt of $7.20B, offset by $532.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Labcorp Holdings Inc.?

Labcorp Holdings Inc. (LH) has total shareholders' equity (book value) of $8.62B ($103.06 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Labcorp Holdings Inc.'s current ratio and liquidity?

Labcorp Holdings Inc. (LH) reported a current ratio of 1.42x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.